INTISARI Sindroma koroner akut (SKA) merupakan kumpulan gejala klinik penyakit arteri koroner trombotik dengan kelainan dasar aterosklerosis yang menyebabkan plak aterom. Diagnosis SKA dari gejala klinis, elektrokardiografi (EKG) dan petanda jantung troponin. Berdasarkan patofisiologi SKA, inflamasi berperan pada semua tahapan aterosklerosis, meliputi inisiasi, pertumbuhan, dan komplikasi. Inflamasi berkontribusi dalam aterogenesis dan aterotrombosis akut. C-reactive protein (CRP) merupakan reaktan fase akut sebagai petanda inflamasi yang bersifat proaterogenik dan aterotrombosis. Inflamasi intralesi dan ekstralesi dapat mempercepat evolusi ateroma dan memicu kejadian akut pada SKA yang ditunjukkan melalui peningkatan kadar high sensitivity-CRP (hs-CRP). High sensitivity-CRP merupakan CRP dengan metode pengukuran deteksi kadar yang lebih rendah yaitu 0,1-15,0 mg/L. Respon sistem inflamasi yang berlebihan semakin meningkatkan CRP, pada gilirannya dapat memediasi kerusakan miokard dan komplikasi jantung. Glukosa merupakan salah satu mediator penting respon inflamasi baik pada diabetes maupun non-diabetes. Stres hiperglikemia adalah petanda yang lebih terkait langsung dengan tingkat kerusakan miokard akut, infark yang lebih besar akan mengaktivasi saraf simpatis dan sekresi hormon counter regulatory lebih lanjut, menyebabkan hiperglikemia lanjut yang memperburuk inflamasi, berpotensi membentuk siklus “lingkaran yang tidak terputus”, mengakibatkan kerusakan membran sel lebih lanjut yang akhirnya menyebabkan kematian. Kadar glukosa yang tinggi menyebabkan up-regulation sintesis CRP di makrofag. Peningkatan hs-CRP dan glukosa merupakan faktor prognostik major adverse cardiac event (MACE) pada SKA. Penelitian ini merupakan studi kohort prospektif, bertujuan mengetahui nilai prognostik hs-CRP dan glukosa saat masuk perawatan rumah sakit pada pasien SKA di ICCU RSUP Dr.Sardjito Yogyakarta dengan luaran MACE berupa: kematian, reinfark, syok kardiogenik, gagal jantung akut, ventricular tachycardia and fibrillation (VT/VF), urgent - percutaneous coronary intervention (PCI), dinilai dalam 7 hari perawatan. Pemeriksaan hs-CRP dan glukosa masing-masing dengan metode immunoturbidimetric dan hexokinase-G6PD. Nilai prognostik dalam bentuk risiko relatif (RR). Kata kunci : Sindroma Koroner Akut, CRP, hs-CRP, glukosa, hiperglikemia, Unstable angina, NSTEMI, STEMI x ABSTRACT Acute coronary syndrome (ACS) is a collection of clinical symptoms of coronary artery disease with thrombotic disorders that cause atherosclerosis basis atherom plaque. ACS diagnosis obtained from the clinical symptoms, electrocardiographic (ECG) and cardiac marker Troponin. Based on the pathophysiology of ACS, inflammation plays a role in all stages of atherosclerosis, including the initiation, growth, and complications of atherosclerotic plaque. Inflammation contributes important in acute atherogenesis and further atherothrombotic. C-reactive protein (CRP) is an acute phase reactant that is a marker of inflammation that is proaterogenic whose role in further atherothrombotic process. Extralesion and intralesional inflammatory can accelerate the evolution of atheroma and trigger acute events in ACS demonstrated through increased levels of highsensitivity CRP (hs-CRP). High-sensitivity CRP is a method of measuring CRP with lower levels of detection is 0.1 to 15.0 mg / L. Excessive inflammatory response system, the increase of CRP which in turn can mediate myocardial damage and cardiac complications. Glucose is one of the important mediators of the inflammatory response in both diabetic and non-diabetic. Stress hyperglycemia is a marker that is more directly related to the rate of acute myocardial damage, larger infarcts activates the sympathetic nervous and counter-regulatory hormone secretion further, causing further hyperglycemia exacerbates inflammation, potentially forming a cycle "unbroken circle", resulting in further damage to the cell membrane in ultimately lead to death. At high glucose levels cause up-regulation of CRP synthesis in macrophages. Increased hs-CRP and glucose is a prognostic factor of major adverse cardiac events (MACE) in ACS. This study is a prospective cohort study which aims to determine the prognostic value of hs-CRP and glucose on admission in patients with ACS in the ICCU Dr.Sardjito Yogyakarta Hospital with a MACE outcomes: death, reinfarction, cardiogenic shock, acute heart failure, ventricular tachycardia and fibrillation (VT/VF), urgent-percutaneous coronary intervention (PCI) were assessed during the 7 days of treatment. Examination of hs-CRP and glucose each with immunoturbidimetric and hexokinase-G6PD method. The results of prognostic value in the form of relative risk (RR). Keywords : Acute Coronary Syndrome, CRP, hs-CRP, glucose, hyperglycemia, Unstable angina, NSTEMI, STEMI xi